Rabya Sayed

1.3k total citations
17 papers, 464 citations indexed

About

Rabya Sayed is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Rabya Sayed has authored 17 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Nephrology and 6 papers in Surgery. Recurrent topics in Rabya Sayed's work include Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Parathyroid Disorders and Treatments (4 papers) and Dermatological and Skeletal Disorders (3 papers). Rabya Sayed is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Parathyroid Disorders and Treatments (4 papers) and Dermatological and Skeletal Disorders (3 papers). Rabya Sayed collaborates with scholars based in United Kingdom, France and United States. Rabya Sayed's co-authors include Andrew Davenport, Philip N. Hawkins, Helen J. Lachmann, Julian D. Gillmore, Ashutosh Wechalekar, Sajitha Sachchithanantham, Carol Whelan, Stanley Fan, Marianna Fontana and Stanley Fan and has published in prestigious journals such as Circulation, Blood and Kidney International.

In The Last Decade

Rabya Sayed

17 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rabya Sayed United Kingdom 8 303 195 97 75 73 17 464
Giovanbattista Vadacca Italy 4 340 1.1× 133 0.7× 35 0.4× 86 1.1× 89 1.2× 4 451
Johann Reisinger Austria 9 446 1.5× 81 0.4× 41 0.4× 222 3.0× 106 1.5× 16 636
R H Falk United Kingdom 8 422 1.4× 132 0.7× 31 0.3× 187 2.5× 101 1.4× 12 635
Nancy Wassef United Kingdom 7 284 0.9× 123 0.6× 71 0.7× 101 1.3× 99 1.4× 23 455
Álvaro Hernández Vicente Spain 9 149 0.5× 41 0.2× 32 0.3× 119 1.6× 33 0.5× 18 414
DaLi Feng United States 8 573 1.9× 329 1.7× 105 1.1× 501 6.7× 163 2.2× 8 936
Arnault Galat France 13 548 1.8× 290 1.5× 119 1.2× 282 3.8× 114 1.6× 28 706
Rohin Francis United Kingdom 8 447 1.5× 263 1.3× 119 1.2× 278 3.7× 100 1.4× 17 669
Eugenia Papakrivopoulou United Kingdom 10 135 0.4× 136 0.7× 51 0.5× 32 0.4× 8 0.1× 13 328
Н А Мухин Russia 7 54 0.2× 83 0.4× 26 0.3× 27 0.4× 14 0.2× 53 221

Countries citing papers authored by Rabya Sayed

Since Specialization
Citations

This map shows the geographic impact of Rabya Sayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rabya Sayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rabya Sayed more than expected).

Fields of papers citing papers by Rabya Sayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rabya Sayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rabya Sayed. The network helps show where Rabya Sayed may publish in the future.

Co-authorship network of co-authors of Rabya Sayed

This figure shows the co-authorship network connecting the top 25 collaborators of Rabya Sayed. A scholar is included among the top collaborators of Rabya Sayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rabya Sayed. Rabya Sayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Taylor, Graham W., Janet A. Gilbertson, Rabya Sayed, et al.. (2019). Proteomic Analysis for the Diagnosis of Fibrinogen Aα-chain Amyloidosis. Kidney International Reports. 4(7). 977–986. 8 indexed citations
2.
Mahmood, Shameem, Frank Bridoux, Christopher P. Venner, et al.. (2015). Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study. The Lancet Haematology. 2(6). e241–e250. 95 indexed citations
3.
Sayed, Rabya, Ashutosh Wechalekar, Janet A. Gilbertson, et al.. (2015). Natural history and outcome of light chain deposition disease. Blood. 126(26). 2805–2810. 77 indexed citations
4.
Mahmood, S., Sajitha Sachchithanantham, Thirusha Lane, et al.. (2015). Bleeding diathesis and prothrombotic tendencies in patients with newly diagnosed systemic light chain Amyloidosis: important clinical implications. Clinical Lymphoma Myeloma & Leukemia. 15. e201–e201. 1 indexed citations
5.
Sayed, Rabya, Janet A. Gilbertson, David F. Hutt, et al.. (2014). Misdiagnosing renal amyloidosis as minimal change disease. Nephrology Dialysis Transplantation. 29(11). 2120–2126. 6 indexed citations
6.
Mahmood, Shameem, Leena George, Milind Sovani, et al.. (2014). High prevalence of sleep disordered breathing (SDB) in patients with systemic AL amyloidosis. European Respiratory Journal. 44(Suppl 58). P4928–P4928. 1 indexed citations
7.
Sayed, Rabya, Dominic Rogers, Fiqe Khan, et al.. (2014). A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis. European Heart Journal. 36(18). 1098–1105. 118 indexed citations
8.
Sayed, Rabya, Philip N. Hawkins, & Helen J. Lachmann. (2014). Emerging treatments for amyloidosis. Kidney International. 87(3). 516–526. 20 indexed citations
9.
Patel, Ketna, Marianna Fontana, Sajitha Sachchithanantham, et al.. (2014). Abstract 16030: Heterogeneity of Electrocardiographic Findings in Cardiac Transthyretin (ATTR) Amyloidosis and Impact on Survival. Circulation. 130(suppl_2). 1 indexed citations
10.
Sayed, Rabya, Terence Cook, & Andrew Palmer. (2013). Recognizing isolated IgG4-related nephropathy. Clinical Kidney Journal. 6(4). 433–435. 1 indexed citations
11.
Sachchithanantham, Sajitha, Shameem Mahmood, Rabya Sayed, et al.. (2013). Biweekly Bortezomib Is More Efficacious Than Weekly Bortezomib When Used As First Line In Patients With Systemic AL Amyloidosis. Blood. 122(21). 1981–1981. 2 indexed citations
12.
Mahmood, Shameem, Sajitha Sachchithanantham, Frank Bridoux, et al.. (2013). Risk Of Progression Of Localised Amyloidosis To Systemic Disease In 606 Patients Over 30 Years. Blood. 122(21). 3143–3143. 4 indexed citations
13.
Sachchithanantham, Sajitha, Anna Baginska, Dorota Rowczenio, et al.. (2013). Use Of Plasma Cell Immunophenotype As Prognostic Markers In Patients With Systemic AL Amyloidosis. Blood. 122(21). 3120–3120. 5 indexed citations
14.
Fan, Stanley, Rabya Sayed, & Andrew Davenport. (2012). Extracellular Volume Expansion in Peritoneal Dialysis Patients. The International Journal of Artificial Organs. 35(5). 338–345. 54 indexed citations
15.
Davenport, Andrew, Rabya Sayed, & Stanley Fan. (2011). Is Extracellular Volume Expansion of Peritoneal Dialysis Patients Associated with Greater Urine Output?. Blood Purification. 32(3). 226–231. 33 indexed citations
16.
Davenport, Andrew, Rabya Sayed, & Stanley Fan. (2011). The Effect of Racial Origin on Total Body Water Volume in Peritoneal Dialysis Patients. Clinical Journal of the American Society of Nephrology. 6(10). 2492–2498. 35 indexed citations
17.
Ashammakhi, Nureddin, András Papp, Rabya Sayed, et al.. (1999). Histological evaluation of poly(L-lactide/epsilon-caprolactone) membrane implanted subcutaneously in rats.. PubMed. 88(4). 313–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026